North Carolina Biotech CEOs – A Roundtable Interview With “The Pink Sheet” DAILY (part 2 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
“The Pink Sheet” DAILY recently talked with the CEOs of five North Carolina-based biotechs. In this portion of the roundtable, we discuss what smaller biotechs look for in collaborations with large pharmaceutical companies and how the smaller firms can position themselves to get the most benefit out of these deals.
You may also be interested in...
North Carolina Biotech CEOs – A Roundtable Interview With “The Pink Sheet” DAILY, Part 1
CEOs from five North Carolina-based biotechs discuss the challenges present in today’s FDA approval process.
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.